← Open Payments lookup

RACHEL CUNNINGHAM: Open Payments

NPI 1750370706 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$754 in 35 payments from 22 companies in 2025. Trend: 2023 $643 · 2024 $671 · 2025 $754

Food & beverage: $754
CompanyPaymentsAmount
Merck Sharp & Dohme LLC3$90
AstraZeneca Pharmaceuticals LP4$84
Novartis Pharmaceuticals Corporation4$74
PFIZER INC.3$54
Daiichi Sankyo Inc.2$44
Celgene Corporation2$44
Takeda Pharmaceuticals U.S.A., Inc.1$37
E.R. Squibb & Sons, L.L.C.2$36
Bayer Healthcare Pharmaceuticals Inc.1$31
EMD Serono, Inc.1$28

Products named: KEYTRUDA, IBRANCE, REBLOZYL, NINLARO, OPDIVO, LYNPARZA, SCEMBLIX, Nubeqa.

Industry payments across LA — which companies pay providers there.